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Abstract
Group A rotavirus (RVA) infections form a major public health problem, especially in low-income countries like the
Democratic Republic of the Congo (COD). However, limited data on RVA diversity is available from sub-Saharan Africa in
general and the COD in particular. Therefore, the first aim of this study was to determine the genetic diversity of 99 RVAs
detected during 2007–2010 in Kisangani, COD. The predominant G-type was G1 (39%) and the most predominant P-type
was P[6] (53%). A total of eight different G/P-combinations were found: G1P[8] (28%), G8P[6] (26%), G2P[4] (14%), G12P[6]
(13%), G1P[6] (11%), G9P[8] (4%), G4P[6] (2%) and G8P[4] (1%). The second aim of this study was to gain insight into the
diversity of P[6] RVA strains in the COD. Therefore, we selected five P[6] RVA strains in combination with the G1, G4, G8 (2x)
or G12 genotype for complete genome analysis. Complete genome analysis showed that the genetic background of the
G1P[6] and G12P[6] strains was entirely composed of genotype 1 (Wa-like), while the segments of the two G8P[6] strains
were identified as genotype 2 (DS-1-like). Interestingly, all four strains possessed a NSP4 gene of animal origin. The analyzed
G4P[6] RVA strain was found to possess the unusual G4-P[6]-I1-R1-C1-M1-A1-N1-T7-E1-H1 constellation. Although the
majority of its genes (if not all), were presumably of porcine origin, this strain was able to cause gastro-enteritis in humans.
The high prevalence of unusual RVA strains in the COD highlights the need for continued surveillance of RVA diversity in the
COD. These results also underline the importance of complete genetic characterization of RVA strains and indicate that
reassortments and interspecies transmission among human and animal RVAs strains occur regularly. Based on these data,
RVA vaccines will be challenged with a wide variety of different RVA strain types in the COD.
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Introduction
Group A rotaviruses (RVAs) are the world’s leading cause of
severe diarrhea in children ,5 years of age and form a major
public health problem, with an estimated 453,000 deaths per year
worldwide. More than 50% of these deaths occur in Africa
(232,000) and 7% of all RVA related deaths occur in the
Democratic Republic of the Congo (COD) (32,653; 95% CI
27,804–37,699) [1]. In fact, the COD, together with India,
Nigeria, Pakistan and Ethiopia, is one of the countries that bear
the highest RVA mortality rates worldwide.
Despite this high burden of disease, only limited regional and
country specific data on RVA genotypes diversity is available from
sub-Saharan Africa in general and the COD in particular. The last
report of the African Rotavirus Surveillance Network reported the
distribution of predominant RVA genotypes among hospitalized
children aged ,5 years between 2007 and 2011 from 16 African
countries [2]. The major G- and P-genotype combinations
detected in this study were G1P[8] (18.4%), G9P[8] (11.7%),
G2P[4] (8.6%), G2P[6] (6.2%), G1P[6] (4.9%), G3P[6] (4.3%),
G8P[6] (3.8%) and G12P[8] (3.1%). Worldwide the majority of
RVA strains infecting humans belong to the G1-G4, G9 and G12
G-genotypes, in combination with the P[4] (for G2) and P[8] (for
G1, G3, G4, G9 and G12) genotypes. When focusing on the
differences in the genetic setup of RVA strains circulating in
Africa, compared to the ones circulating in industrialized
countries, multiple studies have reported the high detection rate
of RVA strains containing the P[6] and G8 genotypes. Both
genotypes are believed to be of animal origin: P[6] RVA strains
(most likely) originated from pigs, while G8 is a genotype often
detected in cows or other members of the mammalian order of the
Artiodactyla [3–10]. The majority of known human G8 RVAs
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strains have been described all over the African continent in
combination with a large number of VP4 specificities and with
different genetic backgrounds [11–23].
Two human RVA vaccines, Rotarix (GlaxoSmithKline) and
RotaTeq (Merck) have been licensed and proven safe in large
clinical trials in the Americas and Europe [24,25]. Data from
clinical trials conducted in five African countries have shown a
lower vaccine immunogenicity and efficacy compared to the ones
observed in America and Europe [26–28]. Despite this observed
lower vaccine efficacy, vaccine introduction in Africa will prevent
a greater number of RVA related deaths due to the substantially
larger mortality rates in Africa compared to the Americas and
Europe. Between August 2009 and May 2014, 21 African
countries (in chronological order: South-Africa, Botswana, Mo-
rocco, Sudan, Ghana, Rwanda, Malawi, Tanzania, The Gambia,
Burkina Faso, Ethiopia, Libya, Zambia, Burundi, Mali, Camer-
oon, Sierra Leone, The Republic of the Congo, Angola,
Madagascar and Zimbabwe) have implemented RVA vaccination
into their national immunization program [29,30].
What factors determine the lower vaccine efficacy in Africa is
not yet completely understood but both host (malnutrition,
competing enteric pathogens, differences in histo-blood group
antigens, the level of anti-rotavirus antibodies in breast milk and a
lower immunological response) and viral (a higher RVA strain
diversity) characteristics have been proposed to (partially) explain
this observation [31–33].
Specific data on RVA strain diversity from the Democratic
Republic of the Congo are scarce with only two currently available
studies dealing with the RVA strain diversity in the COD. The
first study analyzed the complete genomes of two G8 strains
(RVA/Human-wt/COD/DRC86/2003/G8P[6] and RVA/Hu-
man-wt/COD/DRC88/2003/G8P[8]). These strains both pos-
sess a DS-1-like genotype constellation and are the only complete
genomes of Congolese RVA strains available today [13]. The
second study described the epidemiology of RVA associated
gastroenteritis in Kinshasa, COD, from July to October in 2003,
2004, and 2005. The predominant genotypes in 2003 were
G8P[6] and G8P[8] strains while in 2004 and 2005 G1P[6] strains
were predominant [14].
The number of studies conducted in sub-Saharan Africa
involving the analyses of complete genomes of human RVA
strains isolated in Africa is also limited. To our knowledge the
complete genotype constellation of 87 human RVA strains isolated
in sub-Saharan Africa are retrievable from Genbank: 28 of the 87
RVA strains were isolated in Malawi, 22 in Cameroon, 20 in
South-Africa, 4 in Kenya, 3 in Nigeria, 3 in Cote d’Ivoire, 3 in
Zambia, 2 in the COD, 1 in Zimbabwe and 1 in Ethiopia
[11,13,34–38]. Compared to the hundreds of complete genomes
characterized from RVAs isolated in high-income countries, and
considering the large number of co-circulating G/P genotype
combinations, this number is rather low.
The present study aimed to determine the genetic diversity of
RVAs detected during 2007–2010 from Kisangani, COD. In
addition we selected five P[6] RVA strains in combination with the
different observed G-genotypes (G1, G4, 2xG8 and G12) for
complete genome analyses to gain insight into the diversity, origin
and evolution of P[6] RVA strains in the COD.
Methods
Stool sample collection and detection of RVA
Fecal specimens were collected between May 2007 and
December 2010 from children ,5 years old admitted with
gastroenteritis (GE) to the pediatric wards of three hospitals in
Kisangani (University Hospital, General Referral Hospital Maki-
sao of Kisangani – both public hospitals – and Village de Pe´diatrie,
a private hospital center) and screened by an immunochromato-
graphic antigen test (Rota-CIT, BioConcept, Belgium) for the
presence of RVA antigen. Fecal samples containing RVA were
collected and shipped to the Rega Institute for Medical Research
using chromatography paper strips as previously described [39].
Rotavirus genotyping
The paper strips were inserted into an Eppendorf tube with
500 ml of universal transport medium (Copan Diagnostics,
Corona, CA, USA) and thoroughly squeezed using sterile forceps.
An aliquot of 140 ml of the squeezed eluate was used for RNA
extraction using the QIAamp Viral RNA mini kit (QIAGEN/
Westburg, Leusden, The Netherlands) according to the manufac-
turer’s instructions. The G- and P-genotypes of 99 antigen-positive
samples were characterized by reverse-transcription polymerase
chain reaction (RT-PCR) using the QIAGEN OneStep RT-PCR
kit (QIAGEN/Westburg) using primers Beg9 and End9 (VP7),
and VP4_1-17F and Con2 (VP4). Primer sequences are shown in
table S1. PCR products were run on a polyacrylamide gel, stained
with EtBr and visualized under UV-light. The positive samples
were purified with ExoSAP-IT (Affymetrix, Santa Clara, CA,
USA), and Sanger sequenced using the forward primers (Beg9 or
VP4_1-17F) with the ABI PRISM BigDye Terminator cycle
sequencing reaction kit (Applied Biosystems, Foster City, CA,
USA).
Sequencing complete genomes
For the complete genomes, RT-PCR was carried out with an
initial reverse transcription step at 50uC for 30 min followed by a
PCR activation step at 95uC for 15 min, 35 cycles of amplification,
and a final extension step for 10 min at 70uC in a Biometra T3000
thermocycler (Biometra, Westburg BV, Netherlands). For the gene
segments encoding VP6, VP7, NSP1, NSP2, NSP3, NSP4 and
NSP5, the amplification cycle conditions were as follows: 30 s at
94uC, 30 s at 45uC, and 2 min at 72uC. For the larger segments
encoding VP1, VP2, VP3 and VP4 the cycle conditions were 30 s
at 94uC, 30 s at 48uC, and 6 min at 72uC. Primers used to amplify
the VP1, VP2, VP3, VP6, NSP1, NSP2, NSP3, NSP4 and NSP5
gene segments are described in table S1. Primer walking was used
for full-length sequencing of the longest genes (VP1–VP4). The 59
and 39 terminal sequences of the 11 genomic segments were
determined for all five strains using a modified RACE technique as
previously described [40].
Sequence alignment and phylogenetic analysis
The Mega 5.10 software was used for phylogenetic and
molecular evolutionary analyses [41]. To compute evolutionary
distances we used the p-distance nucleotide substitution model. In
phylogenetic analyses we opted for maximum likelihood phyloge-
netic analyses using the complete deletion function in order to
include partially sequenced genes. Bootstrap resampling analysis
(500 replicates) was performed to measure the reliability of the tree
topologies.
Nucleotide sequence accession numbers
Accession numbers from sequences of this study: KJ870690-
KJ870932.
Ethics Statement
Pending the installation of an ethical committee in the Oriental
Province of the COD and at the Kisangani hospitals, the study was
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assessed and approved by the Provincial Health Officer (the
highest ranked medical authority in the Oriental Province) and the
Director’s Board of UH Kisangani, General Reference Hospital of
Makiso and Village de Pe´diatrie, respectively. All samples were
collected in a standard of care setting for therapeutic or diagnostic
reasons. There has been no influence on the treatment of the
patients based on the results of the RVA detection test, and
analyses for this study were performed after installment of the
patients’ treatment. Data were fully anonymized at collection.
Results
1. Rotavirus incidence from May 2007 to December 2010
RVA detection rate and study data. A total of 524 fecal
specimens were collected over the entire study period of which 154
samples (29%) tested positive with the immunochromatographic
antigen test. Figure 1 shows the number of children hospitalized
with gastroenteritis (GE) and the number of RVA positive cases
over the entire study period. There were clear fluctuations in the
number of RVA positive cases and in the number of hospitalized
Figure 1. Numbers of children hospitalized with GE (blue bars) and children hospitalized with GE tested RVA positive (red bars) per
month from May 2007 until December 2010.
doi:10.1371/journal.pone.0100953.g001
Figure 2. Number of hospitalized GE cases (blue bars) and number of hospitalized GE cases tested RVA positive (red bars) pooled
per month over the entire study period. The green line indicates the percentage RVA positive cases tested in each month.
doi:10.1371/journal.pone.0100953.g002
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GE cases per month with a three-month long period (April–June
2008) during which no samples were collected because of stock
rupture. Duration of hospitalizations associated with RVA varied
between 1 and 10 days and occurred among children aged 1 week-
2 years, with a mean age of 10 months.
To determine a possible seasonal variability in RVA disease in
Kisangani, all data shown in figure 1 were pooled per month and
plotted together with the percentage of RVA positive cases in
figure 2. The proportion of RVA positive cases among children
hospitalized with GE ranged between 18.8% and 37.1%, with an
average of 29.0%. RVA infections occurred year-round with three
periods of increased RVA detection rates: February, April–May
and September–November.
2. Genotype distribution
G- and P- genotyping of rotavirus strains. Ninety-nine
samples out of 154 samples were selected, based on the availability
of sufficient stool, for further G and P-genotyping. In the analyzed
samples the predominant G-type was G1 (detected in 39% of
specimens) and the most predominant P-type was P[6] (53%). A
total of eight different G/P-combinations were found: G1P[8]
(N= 28), G8P[6] (N= 26), G2P[4] (N= 14), G12P[6] (N=13),
G1P[6] (N= 11), G9P[8] (N=4), G4P[6] (N=2) and G8P[4]
(N= 1) (figure 3). Only 46% of the isolates were found with the
most typical human RVA genotype combinations (G1P[8],
G2P[4] and G9P[8]). In contrast, 53% of the strains were found
with the P[6] genotype, in combination with the VP7 genotypes
G8, G1, G12 or G4.
To investigate the genetic diversity within the VP4 and VP7
genes isolated in this study phylogenetic trees based on the partial
nucleotide sequences of both genes were constructed (figures 4–5).
For VP4, the majority (53%) of the characterized RVA strains
clustered within the P[6] genotype, more specifically in two
previously defined lineages, P[6]-I and P[6]-V, both of them
containing human and porcine strains [10]. The Congolese RVA
strains belonging to P[6]-I lineage analyzed in this study can be
divided in three different clusters, two large and one smaller cluster
(figure 4). The first large cluster contains the majority (24/26) of
G8P[6] strains while the second big cluster contains all G12P[6]
strains. G1P[6] strains were found in both the G8P[6] as the
G12P[6] clusters (figure 4). The third, smaller cluster contains only
2 G8P[6] strains: RVA/Human-wt/COD/KisB101/2007/
G8P[6] and RVA/Human-wt/COD/KisB605/2008/G8P[6],
the only two G8P[6] strains isolated before 2009. Both G4P[6]
strains detected in this study (KisB332 and KisB503) belonged to
the P[6]-V lineage, a lineage containing mostly porcine or human
strains believed to be of (partial) porcine RVA origin. Both samples
were isolated in 2008, only one month apart from each other in
the same hospital and shared 99.7% nucleotide (nt) identity in
their VP4 genes.
All P[4] strains were found in combination with the G2
genotype, except for a single G8 strain (KisB566). All G2P[4]
strains were very closely related to each other despite the fact that
they were isolated over the entire study period. The fact that the
VP4 gene of KisB566 was almost identical to the G2P[4] strains
suggests a rather recent reassortment event involving the VP7
gene. The P[8] strains from Kisangani showed limited diversity,
with almost identical G1P[8] strains circulating in the Kisangani
area between 2007 and 2009. The only characterized G1P[8]
strain isolated in 2010 (RVA/Human-wt/COD/KisB563/2010/
G1P[8]) was found to cluster closer to the four detected G9P[8]
strains than to the other G1P[8] strains characterized in this study,
again suggesting a recent reassortment event.
For VP7, we found limited diversity within each G-genotype,
especially within G2, G4, G9 and G12 were we found at least
97.9%, 99.2%, 98.7% and 98.2% of nt similarity, respectively.
Within the G1 genotype, two clusters could be defined, one of
which contains only a single Kisangani strain: RVA/Human-wt/
COD/KisB563/2010/G1P[8] (figure 5). This strain is the only
G1P[8] RVA strain isolated in 2010, and shows 94.7% –95.7% nt
similarity with G1P[8] strains isolated between 2007–2009. The
large G1 cluster showed strains with P[6] and P[8] intermingled,
further indicating the frequent occurrence of reassortments. A
clustering according to year of isolation can also be found within
the G8 RVA strains. More specifically, strains isolated in 2007 or
2008 and strains isolated in 2009 or 2010 differ 3.6% to 4.7% on
the nucleotide level.
Both for VP4 and VP7, all strains isolated in Kisangani were
closely related to RVAs present in the global RVA data collection,
in particular to strains isolated from other African patients. For
more detail, extended trees for both VP4 and VP7 were added as
supporting information (Figure S1 for VP4 and Figure S2 for
VP7). Both trees contain twelve representative strains from this
study together with RVA VP4 or VP7 sequences available in
Genbank.
3. Complete genome analysis
Genotype constellations of whole genomes. To gain
insight into the diversity, origin and evolution of P[6] RVA
strains in the COD we selected P[6] strains, based on the
phylogenetic clustering in the VP7 tree and on the viral load of the
samples. In total, the nucleotide sequences of the eleven genes of
five P[6] RVA strains with the different G-genotypes detected in
this study (G1, G4, 2xG8 and G12) were completely determined,
except from the first 33 nucleotides of the VP2 gene of strain
KisB332 which could not be completed due to the lack of sample
available to complete the analysis. Complete genotype assignments
of the five fully sequenced P[6] strains together with a number of
other representative strains are shown in table 1.
The genetic background of the G1P[6] and G12P[6] strains was
entirely composed of genotype 1 (Wa-like). To our knowledge, no
strain with the same genotype constellation as RVA/Human-wt/
COD/KisB504/2009/G1P[6] has previously been reported from
Africa. However, the same constellation was reported in a study
Figure 3. Geographic location of the Democratic Republic of
the Congo on the African continent; location of the city of
Kisangani in the COD together with the genotype distribution
of the 99 analyzed RVA strains. Percentages of the different
genotypes are indicated on the left. The number of strains per
genotype is shown on the right hand side.
doi:10.1371/journal.pone.0100953.g003
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Figure 4. Maximum likelihood tree based on 496 nucleotides of the VP4 encoding gene of the 99 RVA strains characterized in this
study. Tree was rooted using RVA/Human-tc/JPN/AU-1/1982/G3P[9] as an outgroup. Bootstrap values (500 replicates) above 70 are shown. The
strains completely analyzed in this study are marked with a black triangle.
doi:10.1371/journal.pone.0100953.g004
Rotavirus Surveillance in Kisangani
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Figure 5. Maximum likelihood tree based on 363 nucleotides sequence of the VP7 encoding gene of the 99 RVA strains
characterized in this study. Tree was rooted using RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17] as an outgroup. Bootstrap values (500 replicates)
above 70 are shown. The strains completely analyzed in this study are marked with a black triangle.
doi:10.1371/journal.pone.0100953.g005
Rotavirus Surveillance in Kisangani
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Figure 6. Maximum likelihood trees inferred from the nucleotide sequences of RVA VP6, VP1 and VP2 genes. The gene sequence
lengths compared were: VP6 (1064 bp), VP1 (3168 bp), VP2 (2534 bp). The bootstrap values (500 replicates) are shown at the branch nodes (values,
70% not shown). The scale bar is proportional to the genetic distance. An outgroup sequence (RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]) for each
gene was included. Completely sequenced RVA strains from Kisangani are indicated with black triangles.
doi:10.1371/journal.pone.0100953.g006
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Figure 7. Maximum likelihood trees inferred from the nucleotide sequences of RVA VP3, NSP1 and NSP2 genes. The gene sequence
lengths compared were: VP3 (2442 bp), NSP1 (1139 bp), NSP2 (938 bp). The bootstrap values (500 replicates) are shown at the branch nodes (values
,70% not shown). The scale bar is proportional to the genetic distance. An outgroup sequence (RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17] for VP3
and NSP2 and RVA/Horse-wt/ARG/E403/2006/G14P[12] for NSP1) was included. Completely sequenced RVA strains from Kisangani are indicated with
black triangles.
doi:10.1371/journal.pone.0100953.g007
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Figure 8. Maximum likelihood trees inferred from the nucleotide sequences of RVA NSP3, NSP4 and NSP5 genes. The gene sequence
lengths compared were: NSP3 (841 bp), NSP4 (501 bp), NSP5 (542 bp). The bootstrap values (500 replicates) are shown at the branch nodes (values,
70% not shown). The scale bar is proportional to the genetic distance. An outgroup sequence (RVA/Pigeon-tc/JPN/PO-13/1983/G18P[17]) for each
gene was included. Completely sequenced RVA strains from Kisangani are indicated with black triangles.
doi:10.1371/journal.pone.0100953.g008
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investigating 6 Brazilian G1P[6] RVA strains, isolated from
vaccinated children in 2009 and 2010 [42]. The G12-P[6]-I1-R1-
C1-M1-A1-N1-T1-E1-H1 configuration has been previously
reported in two African countries: South-Africa (RVA/Human-
wt/ZAF/3176WC/2009/G12P[6]) and Zambia (RVA/Human-
wt/ZMB/MRC-DPRU3491/2009/G12P[6]) [35]. Both G8P[6]
strains possessed a conserved genomic configuration: G8-P[6]-I2-
R2-C2-M2-A2-N2-T2-E2-H2. This constellation was exactly the
same as that of RVA/Human-wt/COD/DRC86/2003/G8P[6],
also isolated in the COD, and RVA/Human-tc/MWI/QEC29/
2005/G8P[6], isolated in Malawi [11,13].
The G4P[6] strain was found to possess the, for humans
unusual, G4-P[6]-I1-R1-C1-M1-A1-N1-T7-E1-H1 genotype con-
stellation. Although unusual in humans, a recent study describing
G4P[6] strains in Hungarian children, reported three strains with
the exact same genotype constellation as KisB332 [43]. The
genotype constellation I1/I5-R1-C1-M1-A1/A8-N1-T1/T7-E1-
H1 is typically found in pigs with a variety of different G- and P-
genotypes [9,44–46]. A number of recent studies have identified
human G4P[6] strains detected in different parts of the world,
which are believed to be examples of direct interspecies
transmissions, or may have undergone reassortments with human
RVA strains [43,47–51].
Phylogenetic analyses. Despite the different G-genotype, a
very close genetic relationship exists between the G1P[6]
(KisB504) and G12P[6] (KisB521) strain within their segments
VP4 (99.6%), VP6 (99.9%), NSP1 (99.6%), NSP4 (99.8%) and
NSP5 (99.8%). For the remaining genome segments encoding
VP1, VP2, VP3, NSP2 and NSP3 a slightly lower nucleotide
sequence similarity was detected, ranging from 94.4% (for NSP3)
to 98.2% (for NSP2). The genetic similarity between the VP1-4,
VP6, VP7, NSP1-3 and NSP5 of RVA strains KisB521, KisB504
and other recently isolated human Wa-like RVA strains from all
over the world was very high (figure 4–8). The majority of gene
segments of strain KisB521 (VP7, VP4, VP1-3, NSP1, NSP4) and
five gene segments of strain KisB504 (VP4 and NSP1-4) are closely
related to a recently isolated strain from Zambia (RVA/Human-
wt/ZMB/MRC-DPRU3491/2009/G12P[6]).
Both G8P[6] strains clustered very closely together in the
phylogenetic trees of all gene segments, with a nucleotide sequence
similarity ranging between 99.5% and 100% (figure 4–8). These
results indicate a clonal origin of both strains, which were isolated
within a 2-month interval, from patients admitted to the same
hospital. For VP7, VP3, NSP3 and NSP5 these strains shared the
highest nucleotide similarity with RVA/Human-wt/COD/
DRC86/2003/G8P[6]. Human RVA strain DRC86 is the only
completely characterized Congolese G8P[6] strain available in
Genbank until now [13]. Maximal nucleotide sequence identity of
KisB554 and KisB565 was found with RVA strain RVA/Human-
wt/USA/06-242/2006/G2P[6] (VP4, VP6, VP2, NSP1 and
NSP2) and RVA/Human-wt/BEL/B1711/2002/G6P[6] (VP1).
Strain 06–242 was isolated in an American child in 2006 and was
the first G2P[6] strain characterized with a DS-1-like genotype
constellation [52]. Strain B1711 also possessed a complete DS-1-
like genotype constellation and was isolated from a 13-month-old
child admitted to the university hospital in Leuven, Belgium, with
severe gastroenteritis after returning from a trip to Mali [53,54].
Overall, most gene segments of the G8P[6], G1P[6] and
G12P[6] strains appeared to cluster closely to gene segments of
recently isolated human RVA strains from all around the world,
with the exception of NSP4. This gene segment showed more
similarity with porcine/human porcine-like (for the G1P[6],
G12P[6] and G4P[6] strains) or bovine/human bovine-like (for
the G8P[6] strains) RVAs (figure 8). More specific, the three
Congolese strains (and the Zimbabwean strain RVA/Human-wt/
ZMB/MRC-DPRU3491/2009/G12P[6]) belonging to genotype
E1 clustered together with RVA strains RVA/Human-wt/BRA/
NB150/1997/G1G4P[6] and RVA/Human-wt/ECU/EC2184/
200x/G11P[6], both previously classified as porcine-human
reassortants [51,55]. Furthermore, these six strains also felt into
a larger cluster containing porcine RVA strains, or strains believed
to be of porcine origin. On the other hand, the NSP4 encoding
gene segments of the G8P[6] strains belonged to an E2 genotype
cluster containing both animal and human P[14] RVA strains,
which are believed to be the result of direct interspecies
transmissions from sheep or other members of the mammalian
order Artiodactyla [6].
For the G4P[6] strain (KisB332) it appeared that all gene
segments were more closely related to porcine RVA strains or
human porcine-like RVA strains than to typical human RVA
strains. A possible exception is VP7, because it is difficult to
determine the exact origin of the VP7 gene, since there are no
porcine G4 RVA sequences from Africa known today. In general,
the gene segments of KisB332 showed lower nucleotide sequence
identities to known contemporary and historic human or animal
RVAs, especially in the VP6, VP1, VP2 and NSP1 genes (figures 6
and 7). Although these gene segments of KisB332 were only
relatively distantly related to known RVA strains, they showed the
highest relatedness to RVA/Human-wt/NCA/24J/2010/G1P[8]
(for VP6), RVA/Pig-tc/USA/OSU/1977/G5P9[7] (VP1), RVA/
Pig-wt/KOR/K71/2006/G5P7 (VP2) and human reference
strain RVA/Human-tc/USA/WI61/1983/G9P1A[8] (NSP1)
[56,57]. The VP3 of KisB332 was most closely related to porcine
RVA strain OSU (figure 7). The VP4, NSP2, NSP3, NSP4 and
NSP5 genes clustered together with putative porcine interspecies
transmitted RVA strains or human-porcine reassortant strains
(BE2001, Arg4671, NB150, EC2184) [47,51,55,58]. Interestingly,
the NSP3 gene segment of KisB332 belongs to the rarely described
T7 genotype (figure 8). The T7 genotype was first detected in a
bovine RVA strain (RVA/Cow-tc/GBR/UK/1973/G6P7[5])
and was more recently described in a bovine-like human strain
(RVA/Human-xx/IND/Mani-265/2007/G10P[6]) [48,59].
However, an increasing number of studies have reported the T7
genotype in porcine-like human strains (R479, BE2001, BP1901,
BP1490, BP271, BP1792, BP1125, BP1547 and Arg4605) and
porcine RVA strains (CMP45, AB82, F6–4, F8–4-A and TM-a)
derived from different geographical locations [43,46,47,50,58].
The detection of the T7 genotype in strain RVA/Human-wt/
COD/KisB332/2008/G4P[6], a strain with a human porcine-like
gene constellation, makes it more likely that T7 genotypes have
their origins in pigs as was previously suggested in other studies
[46,58].
Discussion
Data shown in figure 2, suggest three periods of increased RVA
detection rates over the course of this study. However, these
fluctuations can be partially explained by sampling bias inherent to
the circumstances in which these samples have been collected.
Kisangani is known for its complex political and economical
climate, making it difficult to collect sufficient samples over a large
period of time without any period of lower or no sampling.
Although the data available in this study do have their limitations,
the available data confirm previous studies that reported year-
round RVA infections in tropical settings, with ups and downs but
no clear period with minimal or no RVA hospitalizations [60,61].
The six most common G/P-genotype combinations in countries
with a more moderate climate and by extension worldwide are
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G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8]. In this
study a high proportion of P[6] RVA strains was observed together
with a large number of unusual strains (G8P[6], G12P[6], G1P[6],
G4P[6] and G8P[4]). These unusual genotype combinations may
represent potential reassortants between human and animal RVA
strains as a result of zoonotic infection. The only way to investigate
this is to perform phylogenetic analysis of complete genomes.
Because of the high number of P[6] RVA strains detected in this
study and the fact that the P[6] genotype is much less prevalent in
high-income countries this study focused on the four different P[6]
genotype combinations detected in Kisangani between May 2007
and December 2010. The majority of the gene segments from the
five P[6] strains characterized in this study appeared to have a
genetic background most closely related to human RVA strains
circulating all over the world. However, all five strains possessed at
least one gene segment (NSP4) that was most closely related to
animal RVAs. One strain, RVA/Human-wt/COD/KisB332/
2008/G4P[6], possessed a majority of gene segments (if not all)
most closely related to porcine, or human porcine-like RVA
strains. For most genome segments KisB332 had still a consider-
able genetic distance to known porcine RVA strains. This can
partly be explained by sampling bias since surveillance studies for
animal rotaviruses are much less common than human rotavirus
surveillance studies. In addition, porcine RVA sequences obtained
from African pigs are not available in Genbank thus far. The lack
of availability of complete genome sequences from porcine RVA
strains in general and from African pig RVAs in particular makes
it difficult to differentiate between the porcine or human origin of
certain gene segments.
The child from which strain KisB332 was isolated lived in close
proximity of a pig farm, providing a plausible route of
transmission. Unfortunately it was not possible to take samples
from the pigs living in close contact with the child. These findings
suggest that KisB332 is of porcine origin and that this strain, after
an interspecies transmission and potential reassortment with
human RVAs, was able to cause gastro-enteritis in a human
child. Surprisingly, a second G4P[6] strain (KisB603) was found in
this study with very similar VP4 and VP7 gene sequences as those
of KisB332. In theory, both strains can be the result of
independent interspecies transmission events but a more plausible
theory would be that the G4P[6] strain was able to spread from
one human to another, although this hypothesis needs further
investigation.
Although interspecies transmission events mostly result in so-
called death-end infections, interspecies transmissions from pigs to
humans seem to occur rather frequently, probably due to the fact
that porcine RVA strains share a similar genetic background with
human Wa-like RVAs [62]. Overall, these results underline the
importance of complete genetic characterization of RVA strains
and indicate that reassortments and interspecies transmission
between human RVAs and porcine RVA strains occur frequently
in the COD. Interspecies transmission events can have a potential
negative influence on the efficacy of RVA vaccines, highlighting
the need for continued surveillance of RVA diversity in the COD.
Based on the data from this study, RVA vaccines will be
challenged with a wider variety of different G- and P- genotypes in
the COD compared to those found in high-income countries. Of
particular importance for the potential implementation of the
currently available RVA vaccines in the COD is the predomi-
nance of P[6] detected in this study (52%) and the high proportion
of strains with the G8 VP7 specificity (27%). Since these genotypes
are not included in the currently available RVA vaccines and the
genotype specific vaccine efficacy against these genotypes is not yet
known, the success of vaccination programs could be lower.
Nevertheless, implementation of rotavirus vaccines in the COD
would be highly recommended to prevent rotavirus related
morbidity and mortality.
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